---
title: Driving simulator improves driving safety
nct_id: NCT06320639
status: RECRUITING
sponsor: University Gustave Eiffel
study_type: OBSERVATIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT06320639"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT06320639"
last_fetched: "2026-05-10T14:05:32.016Z"
source: "Parkinson's Pathways (curated)"
---
# Driving simulator improves driving safety

**Goal (in five words):** Driving simulator improves driving safety

**Official Title:** Driving Simulator and People With Neurocognitive Disorders

**Trial ID:** [NCT06320639](https://clinicaltrials.gov/study/NCT06320639)

## Key Facts

- **Status:** RECRUITING
- **Study Type:** OBSERVATIONAL
- **Sponsor:** University Gustave Eiffel
- **Target Enrollment:** 150 participants
- **Start Date:** 2023-10-03
- **Completion Date:** 2026-10-10
- **Conditions:** Neurocognitive Disorders

## Summary For Families

They want to clarify how neurocognitive disorders affect real-world driving skills, so clinicians can better identify specific driving errors and safety risks. Participants drive in a realistic simulator while researchers measure things like lane keeping, reaction time, braking and hazard response, and record collisions, this is purely observational and not testing a drug or device. The trial seeks 50 to 95-year-olds diagnosed with a DSM-V neurocognitive disorder who have a B license with 3+ years driving experience and are active drivers or stopped less than two months ago, with normal or corrected vision and appropriate consent or a legal representative; people with epilepsy, vestibular problems or severe motion sickness, certain psychiatric histories or unstable psychiatric medications, recent alcoholism, use of anti-epileptics, or major walking-limiting joint problems are excluded.

## Eligibility

- **Minimum age:** 50 Years
- **Maximum age:** 95 Years
- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

* Diagnosed with Neurocognitive Disorders according to the Diagnostic and Statistical Manual of Mental Disorders-V (DSM-V)
* Normal or corrected vision
* B licence holder with 3+ years driving experience
* Active drivers or drivers who stopped driving less than 2 months ago (time between the medical consultation and the day in the day care hospital)
* For participants able to give consent:

  * Written informed consent to participate in the study
  * Informed consent of the participant in the presence of his/her curator.
* For participants who are not able to receive information and to give consent:

  * Written informed consent of the legal representative (tutor) for participants under tutelage.
  * Signature of a relative (family member and/or trusted person) of the participant
* The participant has to be affiliated to a social security scheme.

Exclusion Criteria:

* History of epilepsy
* People with vestibular disorders, motion sickness or migraines
* Psychiatric history (e.g. schizophrenia)
* Non-stabilized use of antidepressants and/or anxiolytics (started or modified within the last 3 months)
* History of alcoholism
* Use of anti-epileptics
* Osteo-articular pathologies compromising walking
```

## Locations (1)

- Hôpital des Charpennes, Villeurbanne, France _(45.7660, 4.8795)_
  - Marion Giroux, PhD — (CONTACT) — 0472432372 — marion.giroux@chu-lyon.fr

## Central Contacts

- Maud Ranchet, PhD — (CONTACT) — 0472142599 — maud.ranchet@univ-eiffel.fr
- Marion Giroux, PhD — (CONTACT) — 0472432372 — marion.giroux@chu-lyon.fr

---

*Canonical: https://parkinsonspathways.com/trial/NCT06320639*  
*HTML version: https://parkinsonspathways.com/trial/NCT06320639*  
*Source data: https://clinicaltrials.gov/study/NCT06320639*